COVIRNA project to host a session at the EHMA 2022 Annual Conference
The COVIRNA project will be participating in the EHMA 2022 Annual Conference with the session ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’, on Friday, 17 June at 11:15 AM CET.
EHMA 2022 Annual Conference is organised by the European Health Management Association (EHMA) – one of the COVIRNA project partners – and is the preeminent European conference on health management, bringing together researchers, academia, health managers, policy and decision-makers to exchange knowledge on innovative practices and excellent delivery of healthcare to ensure the health and well-being for Europe’s citizens and communities. The conference will take place on 15-17 June in Brussels, Belgium under the theme ‘From people to systems: leadership for a sustainable future’.
This session will first examine the impact and benefits of the adoption of novel diagnostic tools in times of pandemic. In particular, it will look at how health managers can help design patient-centred care pathways and create enabling environments for the uptake of innovative tools such as COVIRNA. The session will then discuss how patient-centred care and personalised medicine can improve health outcomes and enhance patients’ quality of life.
In fact, personalised disease management and personalised medicine move away from a one-size-fits-all solution in favour of an approach that recognises the genomic and clinical specificities of each individual patient, and the different forms complex diseases can take. Treatments and care planning can therefore be tailored and adapted to patients to ultimately improve their health outcomes by making treatments more effective and with fewer side effects. Lastly, the session will dive into how we can bring innovations to patients, and how COVIRNA could be used in future pandemics.
Join the session on Friday, 17 June at 11:15 AM CET at the EHMA 2022 Annual Conference to discuss how we can design more patient-centric care pathways together with the following esteemed speakers:
- Dr Yvan Devaux, Head of the Cardiovascular Research Unit at Luxembourg Institute of Health and COVIRNA Project Coordinator
- Dr Damien Gruson, Chief of Department of Laboratory Medicine of the St-Luc Hospital
- Mr Ed Harding, Director of the Heart Failure Policy Network and Managing Director of The Health Policy Partnership
- Prof Sandra Buttigieg, Head of Department Health Systems Management and Leadership at the University of Malta
The session will be moderated by Ms Anett Ruszanov, Director of Policy and Programmes at EHMA.
To learn more about the EHMA 2022 Annual Conference and register, please visit ehmaconference.org.